PyInvesting

Market research

ICAD icad inc

NASDAQ USD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
106M
P/E ratio
Not available
Analyst target
3.75
Dividend yield
Not available
Beta
1.4

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

iCAD, Inc is currently in a long term uptrend where the price is trading 9.7% above its 200 day moving average.

From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 15.5.

iCAD, Inc's total revenue rose by 11.4% to $10M since the same quarter in the previous year.

Its net income has increased by 52.1% to $-2M since the same quarter in the previous year.

Finally, its free cash flow grew by 55.1% to $-1M since the same quarter in the previous year.

Based on the above factors, iCAD, Inc gets an overall score of 5/5.